BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32857984)

  • 1. Onchocerciasis (river blindness) - more than a century of research and control.
    Brattig NW; Cheke RA; Garms R
    Acta Trop; 2021 Jun; 218():105677. PubMed ID: 32857984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
    Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taking the strain out of onchocerciasis? A reanalysis of blindness and transmission data does not support the existence of a savannah blinding strain of onchocerciasis in West Africa.
    Cheke RA; Little KE; Young S; Walker M; Basáñez MG
    Adv Parasitol; 2021; 112():1-50. PubMed ID: 34024357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.
    Loum D; Cozart D; Lakwo T; Habomugisha P; Jacob B; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007558. PubMed ID: 31310607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population biology of human onchocerciasis.
    Basáñez MG; Boussinesq M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data-driven modelling and spatial complexity supports heterogeneity-based integrative management for eliminating Simulium neavei-transmitted river blindness.
    Michael E; Smith ME; Singh BK; Katabarwa MN; Byamukama E; Habomugisha P; Lakwo T; Tukahebwa E; Richards FO
    Sci Rep; 2020 Mar; 10(1):4235. PubMed ID: 32144362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.
    Hernández-González A; Moya L; Perteguer MJ; Herrador Z; Nguema R; Nguema J; Aparicio P; Benito A; Gárate T
    Parasit Vectors; 2016 Sep; 9(1):509. PubMed ID: 27645887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.
    Eisenbarth A; Achukwi MD; Renz A
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004392. PubMed ID: 26926855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward elimination of onchocerciasis in the Americas - 1993-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(20):405-8. PubMed ID: 23698606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onchocerciasis in Sudan: the distribution of the disease and its vectors.
    Baker RH; Abdelnur OM
    Trop Med Parasitol; 1986 Dec; 37(4):341-55. PubMed ID: 3551025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From river blindness control to elimination: bridge over troubled water.
    Colebunders R; Basáñez MG; Siling K; Post RJ; Rotsaert A; Mmbando B; Suykerbuyk P; Hopkins A
    Infect Dis Poverty; 2018 Mar; 7(1):21. PubMed ID: 29587844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
    Abegunde AT; Ahuja RM; Okafor NJ
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vector-parasite transmission complexes for onchocerciasis in West Africa.
    Toé L; Tang J; Back C; Katholi CR; Unnasch TR
    Lancet; 1997 Jan; 349(9046):163-6. PubMed ID: 9111540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onchocerca ochengi: assessment of the Simulium vectors in north Cameroon.
    Wahl G; Ekale D; Schmitz A
    Parasitology; 1998 Apr; 116 ( Pt 4)():327-36. PubMed ID: 9585935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.
    Berger IB; Nnadozie J
    J Am Optom Assoc; 1993 Oct; 64(10):699-702. PubMed ID: 8245390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA probe-based classification of Simulium damnosum s. l.-borne and human-derived filarial parasites in the onchocerciasis control program area.
    Toe L; Merriweather A; Unnasch TR
    Am J Trop Med Hyg; 1994 Nov; 51(5):676-83. PubMed ID: 7985761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli.
    Dadzie KY; Remme J; Baker RH; Rolland A; Thylefors B
    Trop Med Parasitol; 1990 Dec; 41(4):376-82. PubMed ID: 1963702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.